6508-11-8

Usage

Uses

Used in Medicinal Chemistry:
1-(4-chloro-phenyl)-4,5-dihydro-1H-pyrazol-3-ylamine is used as a building block for the synthesis of other organic molecules, particularly in the development of new drugs. Its unique chemical structure allows for the creation of a variety of compounds with potential therapeutic applications.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 1-(4-chloro-phenyl)-4,5-dihydro-1H-pyrazol-3-ylamine is used as a starting material for the development of new drugs. Its potential biological activities make it a valuable compound for exploring novel therapeutic options.
Used in Agrochemicals:
1-(4-chloro-phenyl)-4,5-dihydro-1H-pyrazol-3-ylamine may also be used as a starting material in the development of new agrochemicals, such as pesticides or herbicides, due to its potential biological activities and chemical versatility.
Used in Chemical Research and Laboratory Experiments:
1-(4-CHLORO-PHENYL)-4,5-DIHYDRO-1H-PYRAZOL-3-YLAMINE is used in chemical research to investigate its properties and potential applications. It serves as a valuable tool for scientists and researchers in understanding its interactions with other molecules and its potential uses in various fields.

InChI:InChI=1/C9H10ClN3/c10-7-1-3-8(4-2-7)13-6-5-9(11)12-13/h1-4H,5-6H2,(H2,11,12)

Upstream product

• 1073-70-7 4-chlorophenylhydrazine hydrochloride 
• 107-13-1 acrylonitrile 
• 1073-69-4 N-4-chlorophenylhydrazine 

Downstream Products

• 6119-12-6 1-(4-chlorophenyl)-3-pyrazolidinone 
• 66000-39-3 3-amino-1-(4-chlorophenyl)-1H-pyrazole 
• 64513-52-6 N-[1-(p-Chlorophenyl)-2-pyrazolin-3-yl]acetamide 

Relevant academic research and scientific papers

QUINAZOLINEDIONE DERIVATIVES AS TRPA1 MODULATORS

The present invention provides Quinazolinedione derivatives as TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by T

3-AMINOPYRAZOLINES FOR TREATMENT OF NEURODEGENERATIVE AND PSYCHIATRIC DISEASES

Compounds of the formula (I), inhibit D-amino acid oxidase and hence find use in treating degenerative and psychiatric diseases.

Pharmaceutical formulations

Heterocyclic compounds of formula (I) STR1 and their acid addition salts, when administered topically, exhibit anti-inflammatory activity and do not produce the side-effects associated with the administration of certain other anti-inflammatories. The compounds of formula (I) may be administered topically as the compound alone or in a suitable topical pharmaceutical formulation.

Therapeutically active 3-amino-1-halogenated phenyl-2-pyrazolines and their C4 and C5 analogs

A method of meliorating the inflammation and/or the progressive joint deterioration characteristic of arthritic disease, preventing the onset of asthmatic symptoms and allergic diseases, treating pain or treating bacterial and fungal infections in mammals using 3-amino-1-halogenated phenyl-2-pyrazolines and their C4 and C5 analogs.

3-Trifluoroacetylamino-1-aryl-2-pyrazolines

This disclosure describes novel 3-substituted amino-1-phenyl-2-pyrazolines and 3-substituted amino-1-mono and disubstituted phenyl-2-pyrazolines and their C4 and C5 analogs, useful for meliorating the inflammation and/or the progressive joint deterioration characteristic of arthritic disease, preventing the onset of asthmatic symptoms and allergic diseases, or as analgesic, antibacterial or antifungal agents.

Therapeutically active 3-substituted amino-1-phenyl and substituted phenyl-2-pyrazolines

3-substituted amino-1-phenyl-2-pyrazolines and 3-substituted amino-1-substituted phenyl-2-pyrazolines and their C4 and C5 analogs, useful for meliorating the inflammation and/or the progressive joint deterioration characteristic of a